THE BEAUTY HEALTH COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.24 USD | +5.88% |
|
-0.92% | +4.18% |
| Apr. 10 | Beauty Health Names Sheri Lewis as Chief Supply Chain, Operations Officer | MT |
| Apr. 09 | The Beauty Health Company Announces Termination of Brad Hauser as Chief Operating Officer | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | - | 3,615 | 1,203 | 408.2 | 400 | - | - |
| Enterprise Value (EV) 1 | - | 3,443 | 1,369 | 623.6 | 647.9 | 610.1 | 673.1 |
| P/E ratio | - | -6.58 x | 30.4 x | -4.09 x | -25.4 x | 39.8 x | 13.1 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | 13.9 x | 3.29 x | 1.03 x | 1 x | 0.89 x | 0.81 x |
| EV / Revenue | - | 13.2 x | 3.74 x | 1.57 x | 1.61 x | 1.35 x | 1.36 x |
| EV / EBITDA | - | 105 x | 28.7 x | 25.7 x | 16.5 x | 8.67 x | 8.44 x |
| EV / FCF | - | -78.3 x | -11 x | 71.7 x | 41.4 x | 14.8 x | 15.3 x |
| FCF Yield | - | -1.28% | -9.06% | 1.4% | 2.42% | 6.77% | 6.54% |
| Price to Book | - | - | 7.88 x | 6.89 x | 6.48 x | 6.48 x | - |
| Nbr of stocks (in thousands) | - | 149,640 | 132,208 | 131,267 | 123,459 | - | - |
| Reference price 2 | 11.31 | 24.16 | 9.100 | 3.110 | 3.240 | 3.240 | 3.240 |
| Announcement Date | 3/24/21 | 2/22/22 | 2/28/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 119.1 | 260.1 | 365.9 | 398 | 401.3 | 451.9 | 493.1 |
| EBITDA 1 | - | 32.7 | 47.66 | 24.3 | 39.26 | 70.35 | 79.75 |
| EBIT 1 | - | -36.64 | -24.28 | -130.9 | -16.3 | 9.561 | 22.2 |
| Operating Margin | - | -14.09% | -6.64% | -32.89% | -4.06% | 2.12% | 4.5% |
| Earnings before Tax (EBT) 1 | - | -377.4 | 45.03 | -101.9 | -8.389 | 26.15 | 41.83 |
| Net income 1 | -29.92 | -375.1 | 44.38 | -100.1 | -19.62 | 10.69 | 32.18 |
| Net margin | -25.12% | -144.22% | 12.13% | -25.15% | -4.89% | 2.37% | 6.53% |
| EPS 2 | - | -3.670 | 0.2989 | -0.7600 | -0.1275 | 0.0814 | 0.2469 |
| Free Cash Flow 1 | - | -43.98 | -124 | 8.701 | 15.65 | 41.28 | 44 |
| FCF margin | - | -16.91% | -33.89% | 2.19% | 3.9% | 9.13% | 8.92% |
| FCF Conversion (EBITDA) | - | - | - | 35.81% | 39.86% | 58.67% | 55.17% |
| FCF Conversion (Net income) | - | - | - | - | - | 386.11% | 136.72% |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 3/24/21 | 2/22/22 | 2/28/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 68.15 | 77.89 | 75.42 | 103.5 | 88.79 | 98.13 | 86.3 | 117.5 | 97.41 | 96.8 | 80.59 | 108.2 | 101.7 | 110.1 | 92.16 |
| EBITDA 1 | 5.8 | 8.488 | 2.217 | 12.64 | 16.54 | 16.27 | -0.5 | 17.8 | 9.1 | 3.4 | -6.746 | 10.06 | 16.55 | 24.68 | -0.05 |
| EBIT 1 | -5.456 | -7.212 | -12.96 | -3.413 | -4.141 | -3.765 | -17.3 | -13.1 | -82.1 | -18.4 | -20.98 | -2.88 | 2.26 | 5.26 | -14.68 |
| Operating Margin | -8.01% | -9.26% | -17.19% | -3.3% | -4.66% | -3.84% | -20.05% | -11.15% | -84.28% | -19.01% | -26.03% | -2.66% | 2.22% | 4.78% | -15.92% |
| Earnings before Tax (EBT) 1 | -216.3 | -16.25 | 35.12 | 8.007 | -0.69 | 2.593 | -25.9 | 1.2 | -70.34 | -8.8 | -19.65 | -1.983 | 4.433 | 9.137 | -12.8 |
| Net income 1 | -215.1 | -17.31 | 32.51 | 7.931 | 0.131 | 3.815 | -22.3 | 3.4 | -73.82 | -9.4 | -17.44 | -3.277 | 1.094 | 6.079 | -11.07 |
| Net margin | -315.71% | -22.23% | 43.1% | 7.66% | 0.15% | 3.89% | -25.84% | 2.89% | -75.78% | -9.71% | -21.64% | -3.03% | 1.08% | 5.52% | -12.01% |
| EPS 2 | -1.630 | -0.1200 | 0.2200 | 0.0500 | 0.000900 | 0.0300 | -0.1700 | 0.0300 | -0.5600 | -0.0700 | -0.1365 | -0.0249 | 0.008080 | 0.0470 | -0.0867 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/9/21 | 2/22/22 | 5/10/22 | 8/9/22 | 11/8/22 | 2/28/23 | 5/10/23 | 8/9/23 | 11/13/23 | 3/12/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 166 | 215 | 248 | 210 | 273 |
| Net Cash position 1 | - | 172 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | 3.482 x | 8.862 x | 6.314 x | 2.986 x | 3.424 x |
| Free Cash Flow 1 | - | -44 | -124 | 8.7 | 15.7 | 41.3 | 44 |
| ROE (net income / shareholders' equity) | - | - | 3.84% | -88.4% | -58.2% | 20.2% | 46% |
| ROA (Net income/ Total Assets) | - | - | 0.82% | -10.4% | -1.97% | 0.72% | 3.48% |
| Assets 1 | - | - | 5,429 | 966.1 | 995.9 | 1,493 | 925.4 |
| Book Value Per Share 2 | - | - | 1.150 | 0.4500 | 0.5000 | 0.5000 | - |
| Cash Flow per Share | - | - | 0.2300 | - | - | - | - |
| Capex 1 | - | 15.6 | 17.4 | 13 | 16.7 | 16.5 | 17 |
| Capex / Sales | - | 6% | 4.75% | 3.28% | 4.16% | 3.64% | 3.45% |
| Announcement Date | 3/24/21 | 2/22/22 | 2/28/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
3.24
USD
Average target price
4.49
USD
Spread / Average Target
+38.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.18% | 400M | |
| -3.33% | 249B | |
| +10.09% | 18.86B | |
| 0.00% | 17.37B | |
| -1.32% | 10.65B | |
| -7.73% | 10.26B | |
| +3.86% | 6.72B | |
| +9.76% | 5.94B | |
| -0.06% | 4.55B | |
| -16.98% | 3.83B |
- Stock Market
- Equities
- SKIN Stock
- Financials The Beauty Health Company
